In the work by Ballesteros-Briones et al., we demonstrated the potent antitumor activity of an SFV vector encoding an anti-PD-L1 antibody (SFV-aPDL1) in mouse models of CRC and melanoma [134]. This evidence concerns the gene CD274 and colorectal carcinoma.